SARS-CoV-2, the virus responsible for COVID-19, can impair pancreatic function by binding to angiotensin-converting enzyme 2 (ACE2) receptors expressed in pancreatic islet cells, potentially leading to β-cell dysfunction and hyperglycemia. This evidence concerns the gene ACE2 and COVID-19.